Perspective: SARS-CoV-2, COVID-19 and Haematologists.
作者信息
Gale Robert Peter
机构信息
Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom,
出版信息
Acta Haematol. 2021;144(2):117-121. doi: 10.1159/000508021. Epub 2020 May 6.
Abstract
摘要
相似文献
1
Perspective: SARS-CoV-2, COVID-19 and Haematologists.观点：严重急性呼吸综合征冠状病毒2、冠状病毒病2019与血液科医生。
Acta Haematol. 2021;144(2):117-121. doi: 10.1159/000508021. Epub 2020 May 6.
2
Should we screen patients with hematologic malignancies for COVID-19?我们是否应该对血液系统恶性肿瘤患者进行 COVID-19 筛查？
Hematol Oncol. 2020 Dec;38(5):648-653. doi: 10.1002/hon.2780. Epub 2020 Aug 8.
3
ASH Registry Offers Insights on COVID-19 in Patients with Hematologic Malignancies.ASH 注册研究提供血液系统恶性肿瘤患者 COVID-19 相关信息。
Oncologist. 2021 Feb;26 Suppl 1(Suppl 1):S17-S18. doi: 10.1002/onco.13657. Epub 2020 Dec 28.
4
Managing patients with hematological malignancies during COVID-19 pandemic.在新冠疫情期间管理血液系统恶性肿瘤患者
Expert Rev Hematol. 2020 Aug;13(8):787-793. doi: 10.1080/17474086.2020.1787147. Epub 2020 Jul 12.
5
High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.高死亡率与高假阴性率：血液系统恶性肿瘤患者的新型冠状病毒肺炎感染情况
Leuk Res. 2021 Jul;106:106582. doi: 10.1016/j.leukres.2021.106582. Epub 2021 Apr 24.
6
Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19.低剂量皮质类固醇联合免疫球蛋白可逆转新冠肺炎重症病例的病情恶化。
Signal Transduct Target Ther. 2020 Nov 24;5(1):276. doi: 10.1038/s41392-020-00407-0.
7
Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?托珠单抗与CAR T细胞治疗后感染风险增加无关：对COVID-19有何影响？
Blood. 2020 Jul 2;136(1):137-139. doi: 10.1182/blood.2020006216.
8
Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.在2019冠状病毒病大流行期间优化嵌合抗原受体T细胞疗法的给药
Clin Adv Hematol Oncol. 2020 Jul;18(7):400-403.
9
COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan.多发性骨髓瘤患者的新型冠状病毒肺炎感染：来自维尔茨堡和武汉的德中经验
Ann Hematol. 2021 Mar;100(3):843-846. doi: 10.1007/s00277-020-04184-2. Epub 2020 Jul 18.
10
Association of nirmatrelvir/ritonavir and remdesivir as treatment for SARS-CoV-2 infection in immunocompromised patients with hematologic malignancies. Series of four cases.尼马曲韦/利托那韦和瑞德西韦联合治疗血液恶性肿瘤免疫功能低下患者 SARS-CoV-2 感染。四例系列。
Rev Esp Quimioter. 2023 Dec;36(6):655-657. doi: 10.37201/req/069.2023. Epub 2023 Oct 3.
引用本文的文献
1
COVID-19 in hematological malignancies: Case series and literature review.COVID-19 与血液系统恶性肿瘤：病例系列与文献复习。
Ann Afr Med. 2023 Jul-Sep;22(3):381-384. doi: 10.4103/aam.aam_238_21.
2
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.新型冠状病毒对造血干细胞移植和嵌合抗原受体 T 细胞治疗受者的影响。
Transplant Cell Ther. 2021 Sep;27(9):796.e1-796.e7. doi: 10.1016/j.jtct.2021.07.005. Epub 2021 Jul 10.
3
From the Editor's Desk: Publishing in Times of a Pandemic.来自编辑台：疫情期间的出版事宜。
Acta Haematol. 2021;144(5):473-475. doi: 10.1159/000515758. Epub 2021 Apr 15.
4
A Haematologist's Guide to Coronavirus Disease 2019: Encyclopaedia or Doorstop?血液科医生的2019冠状病毒病指南：百科全书还是镇纸？
Acta Haematol. 2021;144(1):8-9. doi: 10.1159/000510498. Epub 2020 Oct 8.
5
Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective.新型冠状病毒病 2019（COVID-19）：血液学家视角。
Acta Haematol. 2021;144(1):10-23. doi: 10.1159/000510178. Epub 2020 Jul 28.
6
Treating Plasma Cell Myeloma in Developing Countries: Does Everyone Need the Newest Drugs?发展中国家的浆细胞骨髓瘤治疗：是否每个人都需要最新的药物？
Acta Haematol. 2020;143(6):513-515. doi: 10.1159/000505991. Epub 2020 Mar 10.
本文引用的文献
1
Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?间充质基质细胞在冠状病毒病 19（COVID-19）相关严重急性呼吸系统综合征中的有希望的作用？
Blood Rev. 2021 Mar;46:100742. doi: 10.1016/j.blre.2020.100742. Epub 2020 Aug 13.
2
COVID-19 in persons with chronic myeloid leukaemia.新型冠状病毒肺炎在慢性髓性白血病患者中的情况。
Leukemia. 2020 Jul;34(7):1799-1804. doi: 10.1038/s41375-020-0853-6. Epub 2020 May 18.
3
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.皮质类固醇治疗对 SARS-CoV-2、SARS-CoV 或 MERS-CoV 感染患者结局的影响：系统评价和荟萃分析。
Leukemia. 2020 Jun;34(6):1503-1511. doi: 10.1038/s41375-020-0848-3. Epub 2020 May 5.
4
COVID-19 in persons with haematological cancers.COVID-19 与血液系统恶性肿瘤。
Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24.
5
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
6
Tocilizumab treatment in COVID-19: A single center experience.托珠单抗治疗 COVID-19：单中心经验。
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
7
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.巴瑞替尼作为2019新型冠状病毒急性呼吸道疾病的潜在治疗方法。
Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4.
8
A review of cancer immunotherapy toxicity.癌症免疫疗法毒性综述。
CA Cancer J Clin. 2020 Mar;70(2):86-104. doi: 10.3322/caac.21596. Epub 2020 Jan 16.
Zotero 插件